Global forensic testing Leverage USDTL’s worldwide toxicology capabilities to pursue multi-region contracts with healthcare facilities, child protection agencies, DoD, legal services, and analytical labs seeking comprehensive substance abuse testing across diverse specimen types.

Expanded specimen portfolio Position USDTL’s unique assays for alternative specimens (hair, fingernail, umbilical cord, meconium) as a differentiator for customers needing longer detection windows, perinatal exposure insights, and forensic-grade results beyond traditional urine testing.

High panel flexibility Highlight the ability to offer up to 17-panel urine tests and targeted compounds like tramadol, zolpidem, bath salts, and synthetic cannabinoids to address complex clinical and workplace testing needs with scalable solutions.

Strategic leadership Capitalize on recent leadership changes and new investment to drive expansion initiatives, cross-sell opportunities, and rapid onboarding of new clients seeking improved recovery outcomes and validated toxicology testing.

Certifications and reliability Emphasize ISO 170125 accreditation and ongoing certifications to reassure prospective customers about quality, compliance, and defensible testing in forensic and clinical settings, supporting RFPs and enterprise partnerships.